IPO
-
Mineralys in Radnor Raises $192M for Blood Pressure Drug
A public stock offering from Mineralys Therapeutics of Radnor netted $192 million for the company’s development of a new blood pressure drug candidate, lorundrostat, writes…
-
Mineralys in Radnor Raises Funds for new Blood Pressure Treatment
Mineralys Therapeutics, a Radnor biopharmaceutical company is hoping to raise $100 million to develop a new high blood pressure treatment, writes John George for Philadelphia…
-
How to Qualify and Buy IPO Stocks
When a private company goes public, it is an exciting time for investors. That is because the company will now offer an initial public offering…
-
Radnor-Based Avantor IPO Most Valuable Seen in Years
Avantor, a drug-laboratory equipment and chemical supplier, began trading on the New York Stock Exchange Friday, raising about $3 billion for investors with an initial…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
